In a continuation of the search for acetylcholinesterase (AChE) inhibitors, a class of drugs for the treatment of Alzheimer's disease (AD) [1] , we have screened higher terrestrial plants distributed in Taiwan. Recently, we combined HPLC microfractionation with AChE bioassay using 96-well microplates to investigate the active compounds from the stem of Annona glabra L. (Annonaceae), leading to the characterization of 20 compounds, including three new quaternary protoberberines and two potent AChE inhibitors, palmatine and pseudopalmatine [2] . In the present study, we have investigated the EtOH extract of the leaves of the same plant.
The total free bases of the EtOH extract of the A. glabra leaves, obtained by the general acid−base treatment procedure, were fractionated by centrifugal partition chromatography (CPC), followed by separation using general chromatographic methods, to give 14 compounds (1−14) . Twelve of these are known and were characterized by comparison of their spectral data ([α] D , MS, 1 H and 13 C NMR) to those reported for the corresponding compound. They are (−)-N-methylactinodaphnine (1) [3, 4] , (+)-boldine (3) [5] , (+)-boldine (4) [5] , (−)-anolobine (5) [6] , (−)-asimilobine (6) [6, 7] , (+)-norisodomesticine (7) [8] , (−)-roemeroline (8), (+)-reticuline (10) [5] , 5 (+)-1S,2S-reticuline N-oxide (11) [9] , liriodenine (12) [6] , (−)-pallidine (13) , and (+)-stepharine (14) [5] . From the residue, obtained during the extraction of the acid soluble layer of the EtOH extract by chloroform, five known compounds (15−19) were isolated via fractionation and separation over Sephadex LH-20, CPC, and semi-preparative RP-18 columns. They were identified as (+)-magnoflorine (15) [10] , quercetin (16) [11] , quercetin−3-O-β-Dgalactopyranoside (17) [12] , 3-O-β-D-glucopyranoside (18) [11, 12] , and 3-O-α-L-arabinopyranoside (19) [12] . Of these, compounds 17 and 18 are C-4 epimers at the glycon part and were separated by forming a borate complex.
Compound 2 had a molecular formula of C 18 H 17 NO 4 , as deduced from the (+)-HR-ESI-MS. Its 1 H NMR spectrum (CDCl 3 ) was identical to that of (+)-actinodaphnine [5] , both showing three singlets for the aryl protons at δ 6.49 (H-3), 6.75 (H-8), and 7.61, the last being characteristic for H-11, an AX system for the methylenedioxy group (δ 5.89 and 6.04, J = 1.2 Hz), and one methoxy singlet at δ 3.89 (MeO-10). These data, while incorporated with the left-handed optical property, led to the designation of (−)-actinodaphnine for 2. The 6a-R configuration for 2 was confirmed by the CD spectrum, which showed two positive Cotton effects (CE) at 219 and 281 nm and one negative at 239 nm [13] . Compound 9 had a molecular formula of C 18 H 17 NO 5 , as deduced from the (+)-HR-ESI-MS. Its 1 H NMR spectrum (CD 3 OD) was similar to that of 2 except for the presence of an additional AX system for two vicinally coupled aliphatic protons (δ 4.56 and 4.23, J = 2.9 Hz). The 13 C NMR spectrum of 9 (CD 3 OD) was also similar to that of 2 except for the replacement of the C-7 methylene (δ 36.7 in 2) by an oxymethine (δ 69.4), and the C-6a methine being downfield shifted (δ 58.2 vs. 54.8). These data indicated the C-7 position in 9 to be hydroxylated. Analysis of the coupling constant (J 6a,7 = 2.9 Hz) established H-7 to be equatorially oriented. Irradiation of the resonance of H-8 enhanced the signal at δ 4.56, while that at δ 3.89 (OMe) enhanced the H-11 signal (δ 7.75), supporting 9 as 7-hydroxyactinodaphnine. These data, while combined the left handed optical property and the CD spectrum, showing one positive CE at 218 nm and one negative at 239 nm [13] , further established 9 as (−)-(6aS,7R)-7hydroxyactinodaphnine.
The complete 1 H and 13 C NMR assignments of 2 and 9 in CD 3 OD were made on the basis of HMBC spectroscopic analysis.
The inhibitory activities of compounds 1−19 against AChE [2, 14] are shown in Table 1 . Among these, compounds 5 and 8, possessing a 1,2-methylenedioxy group, had better activity, with IC 50 values of 22.4 and 26.3 μM, respectively. Comparison of their anti-AChE activities also led to the following conclusions: (1) compounds with a secondary (NH) or tertiary amine (NMe) group showed similar activity (e.g. 1 vs. 2, 5 vs. 8);
(2) compounds without the 10-OMe group showed better activity (e.g. 5 vs. 2); (3) compounds with a 7-OH group did not increase activity (e.g. 9 vs. 2); (4) structural isomers at C-1, C-2, C-9, and C-10 show little activity change (e.g. 7 vs. 1); (5) structural isomerism at C-1 and C-2 affects the activity (e.g. 3 vs. 4). 
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Extraction and isolation:
The dried and powdered leaves of A. glabra (2.30 kg) were extracted with EtOH (95%, 10 L x 6) to give 576 g of EtOH extract upon condensation under reduced pressure. Most of the EtOH extract (480 g) was triturated with 1N HCl (500 mL × 3). The combined acidic solutions were partitioned against CHCl 3 (1 L × 3) to give the CHCl 3 layer which, after evaporation, gave a fraction (N, 4.48 g) containing neutral and acidic compounds, an aqueous layer, and a residue (A, 8.2 g). The aqueous layer was basified to pH 9.0 by addition of 28% aqueous ammonia and was extracted with CHCl 3 (1 L × 3) to give the total free bases (B, 6.20 g) after evaporation of the combined CHCl 3 layers. Most of the total free bases (B, 6.00 g) were fractionated by CPC, using the upper layer of the solvent system CHCl 3 −MeOH−2.0%HOAc aq (10:10:6) as the mobile phase till fraction 3, then reversing the delivery system to give fraction 4. Recrystallization of fraction 4 (2.92 g) from CHCl 3 yielded 1 (1.38 g). 
Acetylcholinesterase inhibitory assay:
The inhibitory assay against AChE was based on Ellman's reagent [14] and was modified to measure the activity in a 96-well plate [2] . The AChE inhibitor, galanthamine, was used as a positive control. Samples were dissolved in 10%MeOH aq and the final concentration of MeOH in each well was 1%.
